Biotechnology
The Biotechnology industry has a total of 587 stocks, with a combined market cap of $1.23 trillion and total revenue of $111.64 billion.
Market Cap
1.23T
Revenue
111.64B
Profits
-40.11B
PE Ratio
n/a
Profit Margin
-35.93%
Dividend Yield
0.04%
587 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 122.26B | -0.34% | 1,249,081 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 75.12B | 6.17% | 1,460,512 | 15.53B |
| 3 | ARGX | argenx SE | 53.75B | -1.13% | 256,729 | 5.32B |
| 4 | RVMD | Revolution Medicines, Inc. | 40.85B | 6.22% | 1,548,852 | - |
| 5 | ONC | BeOne Medicines AG | 35.81B | -1.57% | 221,066 | 5.74B |
| 6 | RPRX | Royalty Pharma plc | 33.99B | -0.27% | 2,846,335 | 2.44B |
| 7 | ALNY | Alnylam Pharmaceuticals, Inc. | 27.43B | -28.31% | 9,834,972 | 4.80B |
| 8 | INCY | Incyte Corporation | 24.93B | -3.23% | 2,628,279 | 5.82B |
| 9 | ROIV | Roivant Sciences Ltd. | 24.83B | 5.02% | 4,555,313 | 8.26M |
| 10 | BNTX | BioNTech SE | 23.48B | -0.11% | 1,381,266 | 3.23B |
| 11 | MRNA | Moderna, Inc. | 22.98B | 6.29% | 4,446,900 | 2.23B |
| 12 | INSM | Insmed Incorporated | 22.00B | -1.58% | 3,363,242 | 819.56M |
| 13 | GMAB | Genmab A/S | 17.44B | 0.42% | 1,666,067 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 16.55B | -0.39% | 465,674 | 998.25M |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 16.23B | 0.94% | 728,742 | 4.44B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 16.06B | -1.68% | 2,515,637 | 579.96M |
| 17 | EXEL | Exelixis, Inc. | 14.07B | 1.16% | 2,486,599 | 2.38B |
| 18 | CORT | Corcept Therapeutics Incorporated | 12.70B | 27.29% | 4,497,634 | 830.81M |
| 19 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.30B | 1.28% | 1,367,299 | 622.01M |
| 20 | AXSM | Axsome Therapeutics, Inc. | 12.07B | 3.17% | 714,354 | 708.24M |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 11.71B | -1.29% | 1,224,122 | 3.24B |
| 22 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.37B | -9.83% | 1,487,634 | 1.28B |
| 23 | TECH | Bio-Techne Corporation | 11.22B | - | 6,051,852 | 1.21B |
| 24 | CYTK | Cytokinetics, Incorporated | 10.92B | 2.60% | 2,091,857 | 105.82M |
| 25 | KRYS | Krystal Biotech, Inc. | 10.81B | 0.98% | 301,886 | 417.30M |
| 26 | ABVX | ABIVAX Société Anonyme | 10.77B | 4.62% | 1,492,244 | 5.67M |
| 27 | SMMT | Summit Therapeutics Inc. | 10.72B | 5.00% | 2,863,930 | - |
| 28 | APGE | Apogee Therapeutics, Inc. | 10.08B | 0.07% | 840,073 | - |
| 29 | HALO | Halozyme Therapeutics, Inc. | 9.88B | 0.02% | 1,976,801 | 1.51B |
| 30 | SYRE | Spyre Therapeutics, Inc. | 8.93B | 3.71% | 851,358 | - |
| 31 | PTGX | Protagonist Therapeutics, Inc. | 8.92B | 4.24% | 556,349 | 74.06M |
| 32 | IONS | Ionis Pharmaceuticals, Inc. | 8.85B | -1.41% | 2,442,234 | 874.09M |
| 33 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.82B | -0.30% | 2,109,625 | 18.07M |
| 34 | KYMR | Kymera Therapeutics, Inc. | 8.80B | 1.67% | 444,443 | 51.48M |
| 35 | PRAX | Praxis Precision Medicines, Inc. | 8.58B | 5.75% | 516,295 | 7.46M |
| 36 | IMVT | Immunovant, Inc. | 8.15B | 2.25% | 668,075 | - |
| 37 | PCVX | Vaxcyte, Inc. | 8.08B | 5.62% | 817,943 | - |
| 38 | IBRX | ImmunityBio, Inc. | 7.80B | 9.08% | 11,056,049 | 140.98M |
| 39 | TGTX | TG Therapeutics, Inc. | 7.59B | 0.09% | 2,850,404 | 700.35M |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.25B | -0.74% | 448,997 | 217.17M |
| 41 | COGT | Cogent Biosciences, Inc. | 7.07B | 4.52% | 1,835,733 | - |
| 42 | MIRM | Mirum Pharmaceuticals, Inc. | 6.87B | 4.67% | 562,365 | 569.61M |
| 43 | ERAS | Erasca, Inc. | 6.48B | 5.42% | 3,699,714 | - |
| 44 | CGON | CG Oncology, Inc. | 6.44B | 5.66% | 536,256 | 5.07M |
| 45 | BLTE | Belite Bio, Inc | 6.28B | 4.80% | 241,880 | - |
| 46 | PTCT | PTC Therapeutics, Inc. | 6.26B | 1.38% | 1,374,851 | 1.01B |
| 47 | XENE | Xenon Pharmaceuticals Inc. | 6.20B | 1.73% | 541,477 | 7.50M |
| 48 | DNTH | Dianthus Therapeutics, Inc. | 6.16B | 8.21% | 760,523 | 1.34M |
| 49 | DFTX | Definium Therapeutics, Inc. | 5.91B | 5.53% | 1,805,795 | - |
| 50 | ORKA | Oruka Therapeutics, Inc. | 5.90B | 11.12% | 1,327,435 | - |
| 51 | SRRK | Scholar Rock Holding Corporation | 5.87B | -0.14% | 2,098,831 | - |
| 52 | LGND | Ligand Pharmaceuticals Incorporated | 5.87B | 2.87% | 283,317 | 274.48M |
| 53 | TVTX | Travere Therapeutics, Inc. | 5.33B | 3.10% | 1,014,815 | 536.20M |
| 54 | DYN | Dyne Therapeutics, Inc. | 4.80B | 2.51% | 1,924,548 | - |
| 55 | CRSP | CRISPR Therapeutics AG | 4.77B | 1.68% | 1,377,248 | 4.10M |
| 56 | CAI | Caris Life Sciences, Inc. | 4.55B | 3.21% | 4,541,803 | 907.29M |
| 57 | ACAD | ACADIA Pharmaceuticals Inc. | 4.55B | 0.80% | 1,298,574 | 1.10B |
| 58 | EWTX | Edgewise Therapeutics, Inc. | 4.42B | 3.45% | 809,036 | - |
| 59 | MANE | Veradermics, Incorporated | 4.37B | -2.90% | 684,365 | - |
| 60 | CELC | Celcuity Inc. | 4.27B | 5.26% | 1,322,498 | - |
| 61 | RLAY | Relay Therapeutics, Inc. | 4.24B | 5.88% | 1,865,872 | 10.68M |
| 62 | PBLS | Parabilis Medicines, Inc. | 4.11B | 1.57% | 394,837 | - |
| 63 | TNGX | Tango Therapeutics, Inc. | 3.99B | 6.65% | 1,203,530 | 56.99M |
| 64 | DNLI | Denali Therapeutics Inc. | 3.86B | 2.10% | 1,117,485 | - |
| 65 | VKTX | Viking Therapeutics, Inc. | 3.84B | -0.96% | 3,502,324 | - |
| 66 | ELVN | Enliven Therapeutics, Inc. | 3.77B | 1.85% | 647,726 | - |
| 67 | ALMS | Alumis Inc. | 3.69B | 9.74% | 992,164 | 8.40M |
| 68 | LEGN | Legend Biotech Corporation | 3.69B | 1.06% | 2,834,219 | 1.14B |
| 69 | RCUS | Arcus Biosciences, Inc. | 3.55B | 6.81% | 638,034 | 236.00M |
| 70 | GPCR | Structure Therapeutics Inc. | 3.52B | 4.48% | 383,972 | - |
| 71 | ARQT | Arcutis Biotherapeutics, Inc. | 3.50B | 0.47% | 1,265,872 | 415.62M |
| 72 | IDYA | IDEAYA Biosciences, Inc. | 3.46B | 2.28% | 740,710 | 225.27M |
| 73 | TLX | Telix Pharmaceuticals Limited | 3.35B | -0.40% | 68,366 | 803.79M |
| 74 | NAMS | NewAmsterdam Pharma Company N.V. | 3.33B | 1.97% | 611,370 | 22.57M |
| 75 | MBX | MBX Biosciences, Inc. | 3.16B | 3.91% | 547,982 | - |
| 76 | IRON | Disc Medicine, Inc. | 3.03B | 7.52% | 374,863 | - |
| 77 | CLDX | Celldex Therapeutics, Inc. | 3.02B | 2.60% | 743,221 | 865.00K |
| 78 | QURE | uniQure N.V. | 2.90B | 5.29% | 1,777,450 | 18.67M |
| 79 | ATAI | AtaiBeckley Inc. | 2.66B | - | 14,879,255 | 3.49M |
| 80 | KOD | Kodiak Sciences Inc. | 2.65B | 6.22% | 628,857 | - |
| 81 | BEAM | Beam Therapeutics Inc. | 2.64B | 1.81% | 1,453,739 | 164.01M |
| 82 | IMNM | Immunome, Inc. | 2.61B | -0.13% | 595,409 | 4.02M |
| 83 | TRVI | Trevi Therapeutics, Inc. | 2.61B | 1.71% | 1,515,030 | - |
| 84 | TARS | Tarsus Pharmaceuticals, Inc. | 2.56B | 1.74% | 699,098 | 535.08M |
| 85 | RARE | Ultragenyx Pharmaceutical Inc. | 2.56B | 4.16% | 2,675,778 | 670.00M |
| 86 | NRIX | Nurix Therapeutics, Inc. | 2.45B | -0.08% | 1,248,923 | 36.77M |
| 87 | VCEL | Vericel Corporation | 2.43B | 2.12% | 988,460 | 306.30M |
| 88 | NKTR | Nektar Therapeutics | 2.41B | 1.09% | 676,724 | 55.63M |
| 89 | VERA | Vera Therapeutics, Inc. | 2.37B | 1.66% | 2,056,378 | - |
| 90 | PHVS | Pharvaris N.V. | 2.37B | 3.86% | 512,501 | - |
| 91 | NUVB | Nuvation Bio Inc. | 2.33B | 1.67% | 5,372,156 | 143.05M |
| 92 | MLYS | Mineralys Therapeutics, Inc. | 2.31B | -0.61% | 568,052 | - |
| 93 | COAG | Hemab Therapeutics Holdings, Inc. | 2.22B | 6.08% | 820,846 | - |
| 94 | KLRA | Kailera Therapeutics, Inc. | 2.21B | 1.01% | 568,885 | - |
| 95 | VRDN | Viridian Therapeutics, Inc. | 2.20B | 0.10% | 1,056,759 | 70.92M |
| 96 | PVLA | Palvella Therapeutics, Inc. | 2.15B | 5.32% | 157,643 | - |
| 97 | PGEN | Precigen, Inc. | 2.12B | 8.99% | 3,589,342 | 31.60M |
| 98 | SION | Sionna Therapeutics, Inc. | 2.11B | 4.40% | 353,248 | - |
| 99 | IOVA | Iovance Biotherapeutics, Inc. | 2.09B | 2.85% | 14,085,780 | 285.61M |
| 100 | BHVN | Biohaven Ltd. | 2.08B | 2.90% | 1,242,579 | - |
| 101 | HRMY | Harmony Biosciences Holdings, Inc. | 2.08B | - | 601,792 | 899.11M |
| 102 | RAPP | Rapport Therapeutics, Inc. | 2.05B | 4.49% | 216,870 | 20.00M |
| 103 | ZLAB | Zai Lab Limited | 2.05B | -0.55% | 306,755 | 453.28M |
| 104 | ZBIO | Zenas BioPharma, Inc. | 2.04B | 3.80% | 737,774 | 10.00M |
| 105 | SLS | SELLAS Life Sciences Group, Inc. | 2.02B | 1.88% | 3,776,825 | - |
| 106 | ADMA | ADMA Biologics, Inc. | 2.01B | -0.46% | 1,303,399 | 509.86M |
| 107 | URGN | UroGen Pharma Ltd. | 2.00B | 1.58% | 778,701 | 140.49M |
| 108 | NBTX | Nanobiotix S.A. | 1.98B | 6.09% | 151,844 | 38.27M |
| 109 | TYRA | Tyra Biosciences, Inc. | 1.97B | 6.27% | 854,044 | - |
| 110 | AGIO | Agios Pharmaceuticals, Inc. | 1.95B | -6.46% | 3,134,448 | 98.34M |
| 111 | GHRS | GH Research PLC | 1.95B | 1.43% | 388,848 | - |
| 112 | AUPH | Aurinia Pharmaceuticals Inc. | 1.93B | -1.19% | 1,077,768 | 298.30M |
| 113 | GLUE | Monte Rosa Therapeutics, Inc. | 1.92B | 5.19% | 1,690,390 | 42.95M |
| 114 | FBRX | Forte Biosciences, Inc. | 1.88B | 0.59% | 2,367,988 | - |
| 115 | TSHA | Taysha Gene Therapies, Inc. | 1.88B | 4.72% | 3,389,193 | 7.47M |
| 116 | STOK | Stoke Therapeutics, Inc. | 1.87B | 1.90% | 689,479 | 32.08M |
| 117 | MESO | Mesoblast Limited | 1.86B | 2.97% | 179,421 | 65.38M |
| 118 | OCUL | Ocular Therapeutix, Inc. | 1.85B | 1.32% | 2,686,425 | 52.04M |
| 119 | KARD | Kardigan, Inc. | 1.83B | 3.75% | 142,300 | - |
| 120 | LKFT | Lakefront Biotherapeutics NV | 1.83B | -0.29% | 177,984 | 1.20B |
| 121 | FTRE | Fortrea Holdings Inc. | 1.81B | -6.47% | 1,949,473 | 2.68B |
| 122 | GENB | Generate Biomedicines, Inc. | 1.80B | 7.26% | 356,926 | 30.30M |
| 123 | DMRA | Damora Therapeutics, Inc. | 1.80B | 3.11% | 334,001 | - |
| 124 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.74B | 2.43% | 1,251,311 | 204.73M |
| 125 | ABCL | AbCellera Biologics Inc. | 1.74B | 5.57% | 4,332,766 | 79.21M |
| 126 | SNDX | Syndax Pharmaceuticals, Inc. | 1.73B | 1.35% | 1,102,366 | 217.17M |
| 127 | BCAX | Bicara Therapeutics Inc. | 1.73B | 1.47% | 826,571 | - |
| 128 | IMCR | Immunocore Holdings plc | 1.72B | 1.35% | 213,118 | 412.81M |
| 129 | TRAX | First Tracks Biotherapeutics, Inc. | 1.67B | 14.12% | 967,858 | - |
| 130 | SRPT | Sarepta Therapeutics, Inc. | 1.64B | 0.16% | 2,659,742 | 2.18B |
| 131 | ANAB | AnaptysBio, Inc. | 1.63B | 5.56% | 1,069,577 | 232.39M |
| 132 | ZYME | Zymeworks Inc. | 1.63B | 3.18% | 402,858 | 81.26M |
| 133 | RXRX | Recursion Pharmaceuticals, Inc. | 1.61B | 2.36% | 10,403,212 | 66.41M |
| 134 | AAPG | Ascentage Pharma Group International | 1.61B | -1.31% | 2,591 | 82.08M |
| 135 | XNCR | Xencor, Inc. | 1.59B | 10.04% | 1,615,274 | 97.36M |
| 136 | SEPN | Septerna, Inc. | 1.59B | 4.67% | 264,394 | 72.26M |
| 137 | MLTX | MoonLake Immunotherapeutics | 1.57B | 3.32% | 676,759 | - |
| 138 | INVA | Innoviva, Inc. | 1.57B | -1.94% | 508,588 | 420.69M |
| 139 | NTLA | Intellia Therapeutics, Inc. | 1.55B | 2.69% | 3,183,791 | 66.09M |
| 140 | MAZE | Maze Therapeutics, Inc. | 1.53B | 1.32% | 335,018 | 20.00M |
| 141 | VIR | Vir Biotechnology, Inc. | 1.50B | 3.01% | 1,197,340 | 65.50M |
| 142 | AVBP | ArriVent BioPharma, Inc. | 1.43B | 2.06% | 321,063 | - |
| 143 | SVRA | Savara Inc. | 1.40B | 4.92% | 1,240,732 | - |
| 144 | MNKD | MannKind Corporation | 1.31B | 6.75% | 4,130,317 | 360.78M |
| 145 | AVLN | Avalyn Pharma Inc. | 1.30B | 4.31% | 118,569 | - |
| 146 | ABSI | Absci Corporation | 1.29B | 10.72% | 3,728,993 | 1.84M |
| 147 | AKTS | Aktis Oncology, Inc. | 1.27B | 2.72% | 331,086 | 8.28M |
| 148 | IMTX | Immatics N.V. | 1.26B | 2.34% | 1,607,922 | 43.00M |
| 149 | ARDX | Ardelyx, Inc. | 1.25B | 0.80% | 2,591,034 | 427.68M |
| 150 | INBX | Inhibrx Biosciences, Inc. | 1.24B | 6.91% | 275,496 | 1.30M |
| 151 | NVAX | Novavax, Inc. | 1.22B | 1.36% | 2,924,802 | 596.34M |
| 152 | ORIC | ORIC Pharmaceuticals, Inc. | 1.20B | 3.19% | 1,874,746 | - |
| 153 | JBIO | Jade Biosciences, Inc. | 1.19B | 3.36% | 432,794 | - |
| 154 | VOR | Vor Biopharma Inc. | 1.18B | 11.51% | 800,186 | - |
| 155 | LBRX | LB Pharmaceuticals Inc | 1.17B | 4.87% | 513,939 | - |
| 156 | ANRO | Alto Neuroscience, Inc. | 1.11B | 7.15% | 306,138 | - |
| 157 | MGTX | MeiraGTx Holdings plc | 1.11B | 3.10% | 458,025 | 79.76M |
| 158 | CRVS | Corvus Pharmaceuticals, Inc. | 1.11B | 1.15% | 963,009 | - |
| 159 | WVE | Wave Life Sciences Ltd. | 1.11B | -0.86% | 3,044,997 | 65.37M |
| 160 | SPTX | Seaport Therapeutics, Inc. | 1.09B | 2.94% | 102,160 | - |
| 161 | EYPT | EyePoint, Inc. | 1.08B | 7.89% | 1,560,318 | 7.61M |
| 162 | CGEM | Cullinan Therapeutics, Inc. | 1.08B | 1.80% | 489,147 | - |
| 163 | DRTS | Alpha Tau Medical Ltd. | 1.07B | 6.35% | 606,126 | - |
| 164 | IVA | Inventiva S.A. | 1.07B | 2.44% | 694,621 | 7.94M |
| 165 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.04B | 0.86% | 2,255,920 | 69.64M |
| 166 | OLMA | Olema Pharmaceuticals, Inc. | 1.03B | 5.63% | 689,170 | - |
| 167 | AVTX | Avalo Therapeutics, Inc. | 1.03B | 2.00% | 935,219 | 59.00K |
| 168 | SANA | Sana Biotechnology, Inc. | 974.67M | 2.52% | 1,653,353 | - |
| 169 | JANX | Janux Therapeutics, Inc. | 950.14M | 4.14% | 690,194 | 13.73M |
| 170 | ODTX | Odyssey Therapeutics, Inc. | 881.91M | 2.05% | 106,838 | 1.06M |
| 171 | TBPH | Theravance Biopharma, Inc. | 873.31M | - | 398,141 | 109.78M |
| 172 | ABUS | Arbutus Biopharma Corporation | 871.14M | 2.80% | 786,234 | 191.45M |
| 173 | ANNX | Annexon, Inc. | 863.45M | 8.44% | 2,612,645 | - |
| 174 | OMER | Omeros Corporation | 863.44M | 2.23% | 1,164,290 | 9.89M |
| 175 | GERN | Geron Corporation | 859.64M | -4.29% | 18,001,573 | 196.12M |
| 176 | SLDB | Solid Biosciences Inc. | 835.84M | 5.60% | 845,867 | - |
| 177 | KURA | Kura Oncology, Inc. | 826.49M | 4.26% | 1,408,540 | 71.64M |
| 178 | DBVT | DBV Technologies S.A. | 812.86M | 0.58% | 658,409 | 5.04M |
| 179 | DSGN | Design Therapeutics, Inc. | 788.21M | 4.99% | 544,637 | - |
| 180 | AURA | Aura Biosciences, Inc. | 784.23M | 1.43% | 292,923 | - |
| 181 | TENX | Tenax Therapeutics, Inc. | 771.49M | 1.89% | 1,957,782 | - |
| 182 | MNPR | Monopar Therapeutics Inc. | 768.08M | 6.73% | 327,067 | - |
| 183 | SGP | SpyGlass Pharma, Inc. | 759.61M | 3.70% | 95,753 | - |
| 184 | ACRS | Aclaris Therapeutics, Inc. | 743.01M | 3.91% | 1,905,201 | 8.37M |
| 185 | FTH | Faeth Therapeutics, Inc. | 742.94M | -0.38% | 187,677 | - |
| 186 | CADL | Candel Therapeutics, Inc. | 723.18M | 5.00% | 788,043 | - |
| 187 | NVCT | Nuvectis Pharma, Inc. | 717.52M | 10.00% | 299,879 | - |
| 188 | PHAT | Phathom Pharmaceuticals, Inc. | 717.25M | -22.42% | 7,618,222 | 239.66M |
| 189 | CTMX | CytomX Therapeutics, Inc. | 714.07M | 3.47% | 1,757,550 | 35.54M |
| 190 | PHAR | Pharming Group N.V. | 712.11M | -10.49% | 49,553 | 366.48M |
| 191 | RIGL | Rigel Pharmaceuticals, Inc. | 704.19M | -2.59% | 216,079 | 299.77M |
| 192 | DRUG | Bright Minds Biosciences Inc. | 693.64M | 5.02% | 207,012 | - |
| 193 | CLYM | Climb Bio, Inc. | 691.71M | -0.25% | 1,799,155 | - |
| 194 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 680.91M | 3.22% | 293,362 | - |
| 195 | ALLO | Allogene Therapeutics, Inc. | 679.95M | 8.84% | 10,519,754 | 22.00K |
| 196 | OCS | Oculis Holding AG | 676.95M | 3.41% | 474,619 | 1.40M |
| 197 | NGNE | Neurogene Inc. | 669.54M | -0.18% | 93,077 | 925.00K |
| 198 | GYRE | Gyre Therapeutics, Inc. | 647.75M | 3.01% | 45,636 | 117.05M |
| 199 | ACHV | Achieve Life Sciences, Inc. | 646.75M | 2.02% | 828,974 | - |
| 200 | MPLT | MapLight Therapeutics, Inc. | 636.20M | -6.59% | 1,864,131 | - |
| 201 | MDXG | MiMedx Group, Inc. | 636.00M | 0.95% | 6,128,071 | 355.17M |
| 202 | AGMB | AgomAb Therapeutics NV | 628.16M | 2.86% | 68,899 | - |
| 203 | RGNX | REGENXBIO Inc. | 624.43M | 5.20% | 1,215,194 | 87.82M |
| 204 | CBIO | Crescent Biopharma, Inc. | 620.68M | 1.69% | 283,733 | 11.88M |
| 205 | IMMX | Immix Biopharma, Inc. | 608.67M | 4.65% | 1,186,085 | - |
| 206 | CTNM | Contineum Therapeutics, Inc. | 588.84M | 9.53% | 337,655 | - |
| 207 | CRMD | CorMedix Inc. | 587.60M | 4.17% | 1,182,684 | 400.05M |
| 208 | ALT | Altimmune, Inc. | 579.53M | 2.05% | 5,058,960 | 36.00K |
| 209 | ZVRA | Zevra Therapeutics, Inc. | 569.87M | -1.43% | 1,913,791 | 122.29M |
| 210 | RLMD | Relmada Therapeutics, Inc. | 561.16M | 4.09% | 940,040 | - |
| 211 | SPRY | ARS Pharmaceuticals, Inc. | 559.08M | -3.43% | 1,626,860 | 98.99M |
| 212 | STTK | Shattuck Labs, Inc. | 551.33M | 6.36% | 681,623 | 1.00M |
| 213 | SLN | Silence Therapeutics plc | 548.86M | 0.61% | 769,513 | 839.00K |
| 214 | PRME | Prime Medicine, Inc. | 545.46M | -0.33% | 2,162,885 | 4.03M |
| 215 | TECX | Tectonic Therapeutic, Inc. | 537.96M | 0.28% | 185,474 | - |
| 216 | VSTM | Verastem, Inc. | 536.03M | 1.50% | 1,451,540 | 49.59M |
| 217 | ARVN | Arvinas, Inc. | 535.53M | 0.97% | 550,045 | 89.40M |
| 218 | DNA | Ginkgo Bioworks Holdings, Inc. | 528.48M | 6.17% | 641,594 | 151.40M |
| 219 | FDMT | 4D Molecular Therapeutics, Inc. | 526.42M | 4.79% | 539,916 | 88.24M |
| 220 | ZURA | Zura Bio Limited | 526.29M | 4.33% | 409,589 | - |
| 221 | EIKN | Eikon Therapeutics, Inc. | 520.81M | 6.77% | 268,303 | - |
| 222 | ANL | Adlai Nortye Ltd. | 520.00M | 7.35% | 157,640 | 5.00M |
| 223 | RZLT | Rezolute, Inc. | 509.80M | 3.83% | 805,797 | - |
| 224 | ARTV | Artiva Biotherapeutics, Inc. | 506.77M | 4.09% | 230,808 | 251.00K |
| 225 | HELP | Cybin Inc. | 504.55M | 2.91% | 862,149 | - |
| 226 | ASMB | Assembly Biosciences, Inc. | 501.68M | 3.78% | 55,716 | 71.10M |
| 227 | PRLD | Prelude Therapeutics Incorporated | 500.85M | 7.22% | 329,679 | 16.72M |
| 228 | PROK | ProKidney Corp. | 477.25M | 2.60% | 662,209 | 889.00K |
| 229 | VALN | Valneva SE | 472.70M | 0.32% | 12,181 | 180.25M |
| 230 | QTTB | Q32 Bio Inc. | 463.13M | 6.28% | 557,764 | 53.74M |
| 231 | KYTX | Kyverna Therapeutics, Inc. | 455.36M | 5.94% | 642,415 | - |
| 232 | SGMT | Sagimet Biosciences Inc. | 451.41M | 3.84% | 390,190 | - |
| 233 | REPL | Replimune Group, Inc. | 450.89M | -0.74% | 3,415 | - |
| 234 | IKT | Inhibikase Therapeutics, Inc. | 445.56M | 3.17% | 333,308 | 1.00 |
| 235 | CABA | Cabaletta Bio, Inc. | 443.51M | 3.82% | 1,293,342 | - |
| 236 | OVID | Ovid Therapeutics Inc. | 442.34M | 3.49% | 1,286,171 | 7.12M |
| 237 | PRTA | Prothena Corporation plc | 440.29M | -1.75% | 502,233 | 57.94M |
| 238 | SLBT | SL Science Holding Limited | 434.77M | 3.46% | 38,812 | 3.36M |
| 239 | OCGN | Ocugen, Inc. | 426.54M | 5.88% | 3,105,985 | 4.47M |
| 240 | EDIT | Editas Medicine, Inc. | 412.81M | 3.46% | 833,835 | 38.69M |
| 241 | STRO | Sutro Biopharma, Inc. | 411.28M | 6.43% | 148,324 | 99.61M |
| 242 | EVMN | Evommune, Inc. | 408.81M | 2.71% | 357,415 | 10.00M |
| 243 | BNTC | Benitec Biopharma Inc. | 407.44M | -1.58% | 44,757 | - |
| 244 | AUTL | Autolus Therapeutics plc | 407.20M | 4.79% | 1,743,718 | 92.62M |
| 245 | VTVT | vTv Therapeutics Inc. | 405.54M | 3.81% | 65,662 | 36.84M |
| 246 | CCCC | C4 Therapeutics, Inc. | 404.68M | 3.98% | 3,148,474 | 34.86M |
| 247 | PBYI | Puma Biotechnology, Inc. | 401.60M | 1.02% | 260,169 | 227.18M |
| 248 | LRMR | Larimar Therapeutics, Inc. | 399.26M | 5.37% | 1,033,069 | - |
| 249 | IPSC | Century Therapeutics, Inc. | 394.98M | 8.42% | 516,701 | 109.16M |
| 250 | EPRX | Eupraxia Pharmaceuticals Inc. | 388.51M | 9.72% | 1,104,363 | - |
| 251 | SCTX | Scribe Therapeutics Inc. | 384.83M | 11.11% | 149,195 | 36.28M |
| 252 | AVIR | Atea Pharmaceuticals, Inc. | 379.33M | 2.60% | 506,487 | - |
| 253 | ENTA | Enanta Pharmaceuticals, Inc. | 378.02M | 4.42% | 142,361 | 69.21M |
| 254 | XFOR | X4 Pharmaceuticals, Inc. | 377.28M | - | 453,381 | 9.01M |
| 255 | ABEO | Abeona Therapeutics Inc. | 368.76M | 3.85% | 689,001 | 14.54M |
| 256 | UPB | Upstream Bio, Inc. | 357.54M | 2.50% | 320,622 | 3.32M |
| 257 | AGEN | Agenus Inc. | 353.99M | 19.31% | 2,999,520 | 123.87M |
| 258 | DMAC | DiaMedica Therapeutics Inc. | 351.86M | 3.01% | 301,217 | - |
| 259 | RCKT | Rocket Pharmaceuticals, Inc. | 350.51M | 2.23% | 1,126,430 | - |
| 260 | ZNTL | Zentalis Pharmaceuticals, Inc. | 350.24M | 5.35% | 1,002,429 | 26.87M |
| 261 | CMPX | Compass Therapeutics, Inc. | 349.37M | - | 1,913,196 | 850.00K |
| 262 | FENC | Fennec Pharmaceuticals Inc. | 344.24M | 2.69% | 90,551 | 51.00M |
| 263 | LXEO | Lexeo Therapeutics, Inc. | 341.57M | 0.93% | 644,632 | - |
| 264 | PALI | Palisade Bio, Inc. | 340.22M | - | 916,302 | - |
| 265 | LYEL | Lyell Immunopharma, Inc. | 336.20M | 5.78% | 197,918 | 31.00K |
| 266 | CUVL | Clinuvel Pharmaceuticals Limited | 328.39M | 1.54% | 1,575 | 64.24M |
| 267 | VCRE | Vicore Pharma Holding AB (publ) | 324.89M | 3.08% | 1,416 | 370.61K |
| 268 | IRD | Opus Genetics, Inc. | 317.05M | 10.66% | 1,037,194 | 11.98M |
| 269 | VNDA | Vanda Pharmaceuticals Inc. | 311.50M | 2.57% | 989,685 | 217.78M |
| 270 | NMRA | Neumora Therapeutics, Inc. | 305.72M | - | 425,968 | - |
| 271 | FATE | Fate Therapeutics, Inc. | 292.56M | 6.36% | 1,693,518 | 6.32M |
| 272 | OABI | OmniAb, Inc. | 288.50M | 2.05% | 204,213 | 28.94M |
| 273 | BCYC | Bicycle Therapeutics plc | 279.94M | 3.89% | 418,936 | 63.50M |
| 274 | SLGL | Sol-Gel Technologies Ltd. | 278.49M | 3.20% | 42,339 | 18.47M |
| 275 | FHTX | Foghorn Therapeutics Inc. | 278.30M | - | 173,420 | 28.22M |
| 276 | LCTX | Lineage Cell Therapeutics, Inc. | 276.72M | 4.72% | 1,050,101 | 14.78M |
| 277 | IMRX | Immuneering Corporation | 273.67M | 4.32% | 510,070 | - |
| 278 | SABS | SAB Biotherapeutics, Inc. | 272.21M | 2.30% | 208,625 | 114.70K |
| 279 | NAGE | Niagen Bioscience, Inc. | 264.97M | 3.11% | 575,057 | 130.42M |
| 280 | ELDN | Eledon Pharmaceuticals, Inc. | 263.60M | 3.02% | 984,610 | - |
| 281 | ALXO | ALX Oncology Holdings Inc. | 262.40M | 0.26% | 424,494 | - |
| 282 | IFRX | InflaRx N.V. | 253.34M | 4.24% | 1,113,983 | 33.82K |
| 283 | PRQR | ProQR Therapeutics N.V. | 251.20M | 2.89% | 585,648 | 15.73M |
| 284 | AVXL | Anavex Life Sciences Corp. | 250.21M | 8.43% | 1,247,724 | - |
| 285 | FULC | Fulcrum Therapeutics, Inc. | 247.88M | 2.76% | 1,124,724 | 80.00M |
| 286 | ADAG | Adagene Inc. | 246.45M | 0.27% | 131,689 | 7.67M |
| 287 | TTRX | Turn Therapeutics Inc. | 245.75M | 11.04% | 86,853 | - |
| 288 | TRDA | Entrada Therapeutics, Inc. | 243.95M | 3.36% | 594,596 | 5.74M |
| 289 | CAPR | Capricor Therapeutics, Inc. | 242.65M | -36.23% | 28,897,411 | 11.13M |
| 290 | SRZN | Surrozen, Inc. | 241.84M | 8.49% | 1,072,177 | 7.49M |
| 291 | MGNX | MacroGenics, Inc. | 240.27M | 3.00% | 274,225 | 157.08M |
| 292 | OBIO | Orchestra BioMed Holdings, Inc. | 238.92M | 5.00% | 144,196 | 32.72M |
| 293 | CNXU | Conexeu Sciences Inc. | 236.28M | 11.91% | 160,665 | - |
| 294 | ACIU | AC Immune SA | 235.11M | 4.41% | 245,774 | 4.62M |
| 295 | RNAC | Cartesian Therapeutics, Inc. | 227.12M | 4.18% | 98,703 | 1.78M |
| 296 | CHRS | Coherus Oncology, Inc. | 226.75M | 4.26% | 509,537 | 46.88M |
| 297 | TARA | Protara Therapeutics, Inc. | 226.50M | 5.77% | 273,093 | - |
| 298 | CGEN | Compugen Ltd. | 220.86M | 4.24% | 164,815 | 72.66M |
| 299 | GALT | Galectin Therapeutics Inc. | 212.72M | -7.45% | 369,691 | - |
| 300 | CLLS | Cellectis S.A. | 209.63M | -0.35% | 4,176 | 75.11M |
| 301 | WHWK | Whitehawk Therapeutics, Inc. | 207.07M | 5.19% | 263,829 | 7.15M |
| 302 | GLSI | Greenwich LifeSciences, Inc. | 205.79M | 9.53% | 116,969 | - |
| 303 | KROS | Keros Therapeutics, Inc. | 202.27M | 2.51% | 136,319 | 33.18M |
| 304 | RNA | Atrium Therapeutics, Inc. | 196.03M | 2.50% | 91,830 | 36.68M |
| 305 | OTLK | Outlook Therapeutics, Inc. | 194.48M | 4.00% | 9,381,993 | 333.14K |
| 306 | ANTX | AN2 Therapeutics, Inc. | 191.97M | 6.18% | 358,484 | - |
| 307 | IMUX | Immunic, Inc. | 190.57M | 7.20% | 66,909 | - |
| 308 | ACOG | Alpha Cognition Inc. | 190.09M | -0.80% | 164,340 | 10.83M |
| 309 | NBP | NovaBridge Biosciences | 189.66M | 1.86% | 252,896 | - |
| 310 | VYGR | Voyager Therapeutics, Inc. | 189.12M | 4.33% | 306,689 | 36.49M |
| 311 | NERV | Minerva Neurosciences, Inc. | 187.29M | -1.71% | 91,791 | - |
| 312 | PLX | Protalix BioTherapeutics, Inc. | 182.90M | - | 260,069 | 76.38M |
| 313 | PYXS | Pyxis Oncology, Inc. | 181.83M | -1.71% | 638,291 | 13.86M |
| 314 | MDWD | MediWound Ltd. | 181.22M | -1.74% | 68,129 | 14.48M |
| 315 | HUMA | Humacyte, Inc. | 181.09M | 7.52% | 4,081,131 | 2.02M |
| 316 | CAMP | Camp4 Therapeutics Corporation | 180.96M | 6.12% | 48,053 | 3.93M |
| 317 | DTIL | Precision BioSciences, Inc. | 180.62M | 1.60% | 235,440 | 45.07M |
| 318 | LENZ | LENZ Therapeutics, Inc. | 180.60M | 0.70% | 393,301 | 20.99M |
| 319 | ALEC | Alector, Inc. | 179.86M | 6.58% | 453,143 | 18.42M |
| 320 | ARMP | Armata Pharmaceuticals, Inc. | 175.48M | 4.60% | 64,088 | 5.20M |
| 321 | IVVD | Invivyd, Inc. | 171.34M | 7.11% | 2,886,462 | 55.87M |
| 322 | NGEN | NervGen Pharma Corp. | 170.26M | 0.63% | 221,474 | - |
| 323 | ORMP | Oramed Pharmaceuticals Inc. | 168.62M | 3.78% | 150,168 | 2.00M |
| 324 | ARCT | Arcturus Therapeutics Holdings Inc. | 168.26M | 2.25% | 317,750 | 54.71M |
| 325 | IPHA | Innate Pharma S.A. | 168.25M | -4.12% | 23,359 | 10.57M |
| 326 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 167.68M | 1.46% | 138,831 | - |
| 327 | MENS | Jyong Biotech Ltd. | 165.54M | -0.45% | 34,470 | - |
| 328 | INDP | Indaptus Therapeutics, Inc. | 163.07M | -20.88% | 159,508 | - |
| 329 | TNYA | Tenaya Therapeutics, Inc. | 162.75M | 2.03% | 2,101,016 | 225.00K |
| 330 | OKUR | OnKure Therapeutics, Inc. | 161.58M | 1.27% | 62,396 | - |
| 331 | TNXP | Tonix Pharmaceuticals Holding Corp. | 160.84M | 6.10% | 329,080 | 17.56M |
| 332 | KPTI | Karyopharm Therapeutics Inc. | 158.87M | 2.19% | 4,307,268 | 151.12M |
| 333 | ABOS | Acumen Pharmaceuticals, Inc. | 156.73M | 2.84% | 333,327 | - |
| 334 | MIST | Milestone Pharmaceuticals Inc. | 156.46M | 10.58% | 1,668,269 | 1.78M |
| 335 | MOLN | Molecular Partners AG | 155.33M | - | 87 | 856.30K |
| 336 | YDES | YD Bio Limited | 154.70M | -3.04% | 28,812 | 510.36K |
| 337 | NKTX | Nkarta, Inc. | 153.82M | 0.94% | 751,978 | - |
| 338 | KRRO | Korro Bio, Inc. | 150.72M | 3.77% | 129,677 | 3.84M |
| 339 | CRBU | Caribou Biosciences, Inc. | 149.76M | 2.72% | 916,253 | 11.20M |
| 340 | CBUS | Cibus, Inc. | 147.32M | -0.52% | 190,809 | 4.29M |
| 341 | EQ | Equillium, Inc. | 146.69M | 1.75% | 395,253 | 4.39M |
| 342 | KZIA | Kazia Therapeutics Limited | 146.49M | 6.57% | 328,532 | 1.27M |
| 343 | ENTX | Entera Bio Ltd. | 145.41M | -1.67% | 1,362,362 | 42.00K |
| 344 | UNCY | Unicycive Therapeutics, Inc. | 145.18M | 11.81% | 792,047 | - |
| 345 | CNTN | Canton Strategic Holdings, Inc. | 142.68M | -4.15% | 1,184,175 | - |
| 346 | AARD | Aardvark Therapeutics, Inc. | 139.62M | 20.30% | 152,373 | - |
| 347 | HURA | TuHURA Biosciences, Inc. | 138.19M | 6.37% | 258,556 | - |
| 348 | GNLX | Genelux Corporation | 135.45M | 7.77% | 236,465 | 8.00K |
| 349 | CDXS | Codexis, Inc. | 134.53M | 0.68% | 736,196 | 78.09M |
| 350 | PMN | ProMIS Neurosciences, Inc. | 133.80M | 6.12% | 45,753 | - |
| 351 | CNTB | Connect Biopharma Holdings Limited | 131.59M | 1.95% | 100,128 | 233.00K |
| 352 | NAUT | Nautilus Biotechnology, Inc. | 131.07M | -0.96% | 1,216,202 | 190.00K |
| 353 | NRXP | NRx Pharmaceuticals, Inc. | 130.76M | -3.41% | 1,949,464 | 2.29M |
| 354 | CUE | Cue Biopharma, Inc. | 127.69M | 8.53% | 267,358 | 32.73M |
| 355 | TLSA | Tiziana Life Sciences Ltd | 125.43M | 1.17% | 15,314 | - |
| 356 | PEPG | PepGen Inc. | 123.12M | 4.09% | 466,934 | - |
| 357 | ANIX | Anixa Biosciences, Inc. | 121.12M | 2.30% | 124,947 | - |
| 358 | SPRB | Spruce Biosciences, Inc. | 119.37M | 4.63% | 59,129 | 697.00K |
| 359 | ENGN | enGene Therapeutics Inc. | 117.90M | -1.68% | 731,177 | - |
| 360 | SEER | Seer, Inc. | 113.26M | -0.96% | 756,579 | 15.17M |
| 361 | VANI | Vivani Medical, Inc. | 112.11M | 3.17% | 88,988 | - |
| 362 | RANI | Rani Therapeutics Holdings, Inc. | 111.86M | -2.80% | 234,378 | 3.17M |
| 363 | GUTS | Fractyl Health, Inc. | 109.47M | - | 686,826 | 3.00K |
| 364 | FBIO | Fortress Biotech, Inc. | 109.29M | -1.79% | 463,962 | 66.16M |
| 365 | PLYX | Polaryx Therapeutics, Inc. | 101.79M | 8.04% | 125,917 | - |
| 366 | ICCC | ImmuCell Corporation | 100.06M | 0.45% | 24,899 | 29.93M |
| 367 | BDTX | Black Diamond Therapeutics, Inc. | 98.27M | 3.31% | 536,239 | 70.00M |
| 368 | ALDX | Aldeyra Therapeutics, Inc. | 96.51M | -0.62% | 493,205 | - |
| 369 | COYA | Coya Therapeutics, Inc. | 95.71M | 5.43% | 151,354 | 7.94M |
| 370 | ACET | Adicet Bio, Inc. | 95.14M | 9.16% | 60,657 | - |
| 371 | HRTX | Heron Therapeutics, Inc. | 94.15M | 0.79% | 964,766 | 150.71M |
| 372 | YARW | Yarrow Bioscience, Inc. | 92.37M | 8.34% | 22,085 | - |
| 373 | PTHS | Pelthos Therapeutics Inc. | 91.24M | 1.98% | 165,556 | 27.70M |
| 374 | NTHI | NeOnc Technologies Holdings, Inc. | 90.51M | -0.29% | 29,384 | 39.99K |
| 375 | VRCA | Verrica Pharmaceuticals Inc. | 90.36M | 1.54% | 7,012 | 37.16M |
| 376 | ONCY | Oncolytics Biotech Inc. | 89.87M | 0.19% | 986,965 | - |
| 377 | BMEA | Biomea Fusion, Inc. | 88.21M | - | 322,966 | - |
| 378 | GOSS | Gossamer Bio, Inc. | 87.16M | -13.74% | 30,420,405 | 55.54M |
| 379 | OKYO | OKYO Pharma Limited | 87.12M | 1.22% | 32,960 | - |
| 380 | TELO | Telomir Pharmaceuticals, Inc. | 85.97M | 3.31% | 69,248 | - |
| 381 | RLYB | Rallybio Corporation | 85.14M | 0.69% | 12,046 | 858.00K |
| 382 | PYPD | PolyPid Ltd. | 83.79M | 7.11% | 133,372 | - |
| 383 | KLRS | Kalaris Therapeutics, Inc. | 82.80M | 2.35% | 76,134 | - |
| 384 | CGTX | Cognition Therapeutics, Inc. | 81.98M | 1.65% | 259,321 | - |
| 385 | ATHE | Alterity Therapeutics Limited | 79.84M | 1.24% | 9,525 | 4.43M |
| 386 | NRXS | NeurAxis, Inc. | 77.77M | 3.97% | 165,821 | 4.28M |
| 387 | MAIA | MAIA Biotechnology, Inc. | 76.00M | 4.17% | 290,594 | - |
| 388 | ALPS | Alps Group Inc | 75.35M | 2.91% | 3,893 | 3.74M |
| 389 | ANVS | Annovis Bio, Inc. | 75.30M | 4.12% | 374,315 | - |
| 390 | GANX | Gain Therapeutics, Inc. | 75.07M | 4.14% | 696,126 | - |
| 391 | ATRA | Atara Biotherapeutics, Inc. | 73.61M | 1.36% | 95,964 | 23.14M |
| 392 | CSBR | Champions Oncology, Inc. | 73.08M | -3.66% | 16,402 | 59.43M |
| 393 | RNTX | Rein Therapeutics Inc. | 71.45M | 1.32% | 182,103 | - |
| 394 | SPRO | Spero Therapeutics, Inc. | 69.48M | 0.84% | 487,669 | 61.19M |
| 395 | OSTX | OS Therapies Incorporated | 69.48M | 5.41% | 239,202 | - |
| 396 | IBIO | iBio, Inc. | 69.05M | 2.21% | 422,382 | 300.00K |
| 397 | LONA | LeonaBio, Inc. | 68.48M | 3.55% | 18,198 | - |
| 398 | XBIT | XBiotech Inc. | 68.29M | -0.44% | 6,981 | - |
| 399 | ELTX | Elicio Therapeutics, Inc. | 68.25M | 0.69% | 177,904 | - |
| 400 | IMA | ImageneBio, Inc. | 66.66M | 6.10% | 4,697 | 800.00K |
| 401 | MNOV | MediciNova, Inc. | 65.96M | 3.88% | 64,068 | 596.64K |
| 402 | PLRX | Pliant Therapeutics, Inc. | 65.64M | 0.95% | 173,506 | - |
| 403 | ACRV | Acrivon Therapeutics, Inc. | 65.06M | 6.29% | 384,323 | - |
| 404 | CING | Cingulate Inc. | 64.11M | 5.19% | 124,726 | - |
| 405 | HYFT | MindWalk Holdings Corp. | 63.06M | 3.85% | 103,031 | 11.43M |
| 406 | PMVP | PMV Pharmaceuticals, Inc. | 60.26M | 5.61% | 480,872 | - |
| 407 | CRDF | Cardiff Oncology, Inc. | 58.18M | 5.06% | 1,385,670 | 525.00K |
| 408 | BOLD | Boundless Bio, Inc. | 56.16M | 0.81% | 99,087 | - |
| 409 | CNTX | Context Therapeutics Inc. | 55.80M | -1.57% | 1,089,748 | - |
| 410 | XLO | Xilio Therapeutics, Inc. | 54.32M | -0.22% | 4,956 | 53.48M |
| 411 | INO | Inovio Pharmaceuticals, Inc. | 53.97M | -36.92% | 33,387,790 | 65.34K |
| 412 | ELOX | Eloxx Pharmaceuticals, Inc. | 53.68M | 8.66% | 18,875 | - |
| 413 | DWTX | Dogwood Therapeutics, Inc. | 53.13M | 2.60% | 7,984 | - |
| 414 | INKT | MiNK Therapeutics, Inc. | 52.76M | 2.02% | 5,839 | - |
| 415 | MREO | Mereo BioPharma Group plc | 50.28M | 2.77% | 759,488 | 500.00K |
| 416 | VRXA | Veraxa Biotech AG | 49.43M | -0.51% | 91,169 | - |
| 417 | TCRX | TScan Therapeutics, Inc. | 49.39M | 1.90% | 409,469 | 9.14M |
| 418 | TIL | Instil Bio, Inc. | 48.42M | -1.11% | 7,874 | - |
| 419 | ATYR | aTyr Pharma, Inc. | 47.06M | -0.62% | 625,037 | 190.00K |
| 420 | INMB | INmune Bio Inc. | 47.06M | 4.73% | 134,174 | 50.00K |
| 421 | IMMP | Immutep Limited | 46.95M | -0.26% | 77,386 | 5.28M |
| 422 | EDSA | Edesa Biotech, Inc. | 46.68M | -2.05% | 76,296 | - |
| 423 | BYSI | BeyondSpring Inc. | 46.47M | -1.74% | 13,472 | 1.88M |
| 424 | FLNA | Filana Therapeutics, Inc. | 46.38M | 10.40% | 330,706 | - |
| 425 | IBO | Impact BioMedical Inc. | 46.36M | 0.82% | 9,471 | 39.00K |
| 426 | MCRB | Seres Therapeutics, Inc. | 46.29M | 2.80% | 50,377 | 1.15M |
| 427 | MGX | Metagenomi Therapeutics, Inc. | 45.93M | 0.83% | 131,209 | 22.33M |
| 428 | RNXT | RenovoRx, Inc. | 42.45M | 4.80% | 111,710 | 1.49M |
| 429 | HYPD | Hyperion DeFi, Inc. | 40.32M | 13.68% | 211,610 | 1.04M |
| 430 | PDSB | PDS Biotechnology Corporation | 39.02M | 4.39% | 124,721 | - |
| 431 | EXOZ | eXoZymes, Inc. | 39.00M | 4.55% | 4,697 | -700.00 |
| 432 | DYAI | Dyadic International, Inc. | 38.99M | 0.94% | 154,735 | 3.81M |
| 433 | RADX | Radiopharm Theranostics Limited | 38.55M | 1.59% | 66,938 | 10.86M |
| 434 | APLM | Apollomics, Inc. | 38.10M | -0.74% | 3,552 | 8.84M |
| 435 | VERU | Veru Inc. | 35.63M | 0.45% | 126,337 | 16.89M |
| 436 | GNTA | Genenta Science S.p.A. | 35.62M | 16.15% | 90,782 | - |
| 437 | NTRB | Nutriband Inc. | 35.37M | 1.04% | 3,931 | 1.80M |
| 438 | NNVC | NanoViricides, Inc. | 35.31M | 0.65% | 173,010 | - |
| 439 | CRVO | CervoMed Inc. | 34.09M | 1.61% | 187,111 | 2.09M |
| 440 | LTRN | Lantern Pharma Inc. | 33.81M | 5.58% | 77,079 | - |
| 441 | GRCE | Grace Therapeutics, Inc. | 33.69M | -0.48% | 296,903 | - |
| 442 | LITS | Lite Strategy, Inc. | 33.59M | 3.77% | 106,596 | - |
| 443 | ENLV | Enlivex Ltd. | 31.34M | -13.33% | 308,723 | - |
| 444 | ESLA | Estrella Immunopharma, Inc. | 30.99M | -7.57% | 32,917 | - |
| 445 | SER | Serina Therapeutics, Inc. | 30.59M | -1.45% | 12,096 | 130.00K |
| 446 | BCTX | BriaCell Therapeutics Corp. | 29.82M | 6.76% | 70,637 | - |
| 447 | TVGN | Tevogen Bio Holdings Inc. | 28.35M | 13.13% | 24,206 | - |
| 448 | ACTU | Actuate Therapeutics, Inc. | 27.99M | 8.33% | 263,049 | - |
| 449 | KYNB | Kyntra Bio, Inc. | 27.49M | 0.15% | 5,872 | 7.44M |
| 450 | ABVC | ABVC BioPharma, Inc. | 27.29M | 6.93% | 118,686 | 797.92K |
| 451 | ALGS | Aligos Therapeutics, Inc. | 26.73M | 1.65% | 98,767 | 4.71M |
| 452 | ATNM | Actinium Pharmaceuticals, Inc. | 26.26M | 0.01% | 26,311 | 90.00K |
| 453 | PSTV | Plus Therapeutics, Inc. | 25.12M | 0.55% | 51,913 | 5.18M |
| 454 | IGC | IGC Pharma, Inc. | 24.97M | 3.96% | 245,435 | 1.11M |
| 455 | HOWL | Werewolf Therapeutics, Inc. | 24.32M | 8.78% | 666,681 | 1.14M |
| 456 | EVAX | Evaxion A/S | 23.60M | -0.35% | 7,995 | 7.53M |
| 457 | BRNS | Barinthus Biotherapeutics plc | 22.75M | -2.91% | 26,381 | 14.97M |
| 458 | QNCX | Quince Therapeutics, Inc. | 22.52M | 4.68% | 58,698 | - |
| 459 | PLRZ | Polyrizon Ltd. | 21.75M | -0.68% | 27,101 | - |
| 460 | LGVN | Longeveron Inc. | 21.34M | 13.50% | 484,058 | 1.22M |
| 461 | CVM | CEL-SCI Corporation | 21.32M | 7.02% | 112,728 | - |
| 462 | NEUP | Neuphoria Therapeutics Inc. | 21.19M | 3.16% | 70,975 | -13.27K |
| 463 | SKYE | Skye Bioscience, Inc. | 20.39M | -5.64% | 202,954 | - |
| 464 | GRDX | GridAI Technologies Corp. | 20.29M | 17.31% | 124,000 | - |
| 465 | CLRB | Cellectar Biosciences, Inc. | 20.22M | 2.02% | 30,164 | - |
| 466 | TVRD | Tvardi Therapeutics, Inc. | 19.70M | -1.87% | 331,188 | - |
| 467 | CELU | Celularity Inc. | 19.68M | 1.48% | 18,080 | 26.55M |
| 468 | ALLR | Allarity Therapeutics, Inc. | 19.57M | 6.03% | 55,911 | 345.00K |
| 469 | ATOS | Atossa Therapeutics, Inc. | 18.86M | -5.19% | 32,217 | - |
| 470 | MRKR | Marker Therapeutics, Inc. | 18.67M | 0.90% | 72,943 | 3.55M |
| 471 | DARE | Daré Bioscience, Inc. | 18.57M | 6.90% | 144,761 | 1.16M |
| 472 | NXTC | NextCure, Inc. | 18.17M | 0.20% | 883,068 | - |
| 473 | QNTM | Quantum BioPharma Ltd. | 18.16M | 0.35% | 48,290 | - |
| 474 | NCEL | NewcelX Ltd. | 18.10M | -4.51% | 9,655 | - |
| 475 | LPCN | Lipocine Inc. | 17.40M | 1.93% | 58,344 | 2.00M |
| 476 | JSPR | Jasper Therapeutics, Inc. | 17.38M | 3.45% | 498,966 | - |
| 477 | CTXR | Citius Pharmaceuticals, Inc. | 17.35M | 11.07% | 1,760,511 | 5.61M |
| 478 | PLUR | Pluri Inc. | 16.83M | -1.27% | 11,387 | 1.08M |
| 479 | NRSN | NeuroSense Therapeutics Ltd. | 16.83M | -0.87% | 150,287 | - |
| 480 | PTN | Palatin Technologies, Inc. | 15.25M | -3.34% | 14,035 | 12.88M |
| 481 | OSRH | OSR Health, Inc. | 15.10M | -9.28% | 502,066 | 2.63M |
| 482 | MLEC | Moolec Science SA | 14.98M | -0.33% | 3,439 | 7.83M |
| 483 | CYCN | Cyclerion Therapeutics, Inc. | 14.84M | - | 3,537 | 1.99M |
| 484 | KTTA | Pasithea Therapeutics Corp. | 14.84M | -1.33% | 572,203 | - |
| 485 | PASG | Passage Bio, Inc. | 14.40M | -0.66% | 5,216 | - |
| 486 | BIOT | Instinct Brothers Co., Ltd. | 14.38M | -10.91% | 2,300,949 | - |
| 487 | HIND | Vyome Holdings, Inc. | 14.11M | 1.01% | 2,318 | 152.72K |
| 488 | AKTX | Akari Therapeutics, Plc | 14.00M | -3.03% | 69,086 | - |
| 489 | BLRX | BioLineRx Ltd. | 13.62M | -1.82% | 7,122 | 1.40M |
| 490 | KALA | KALA BIO, Inc. | 13.57M | 8.36% | 95,090 | - |
| 491 | CALC | CalciMedica, Inc. | 13.27M | 13.09% | 311,445 | - |
| 492 | PBM | Psyence Biomedical Ltd. | 12.82M | 12.75% | 423,731 | - |
| 493 | TPST | Tempest Therapeutics, Inc. | 12.79M | -3.22% | 42,176 | - |
| 494 | ICU | SeaStar Medical Holding Corporation | 12.79M | -2.15% | 49,237 | 1.44M |
| 495 | PHIO | Phio Pharmaceuticals Corp. | 11.97M | 4.65% | 82,975 | - |
| 496 | COCP | Cocrystal Pharma, Inc. | 11.96M | -0.30% | 23,383 | 225.00K |
| 497 | GDTC | CytoMed Therapeutics Limited | 11.71M | 8.73% | 8,971 | 669.28K |
| 498 | KPRX | Kiora Pharmaceuticals, Inc. | 11.32M | -0.58% | 4,630 | 20.00K |
| 499 | SNTI | Senti Biosciences Holdings, Inc. | 11.22M | 3.86% | 132,361 | 38.00K |
| 500 | GTBP | GT Biopharma, Inc. | 11.10M | 1.99% | 457,716 | - |